Managed Account Advisors’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Managed Account Advisors’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-20,836	Closed	-$523K	–	3115
2014 Q4	$523K	Sell	20,836 -3,374	-14%	-$99K	﹤0.01%	2196
2014 Q3	$753K	Sell	24,210 -16,721	-41%	-$453K	﹤0.01%	2112
2014 Q2	$1.06M	Sell	40,931 -14,230	-26%	-$316K	﹤0.01%	1992
2014 Q1	$1.29M	Buy	55,161 +7,116	+15%	+$156K	﹤0.01%	1887
2013 Q4	$1.22M	Buy	+48,045	New	+$1.08M	﹤0.01%	1866

Other funds holding SGNT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Managed Account Advisors's SGNT Position: Q1 2015 in Review

Managed Account Advisors sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q1 2015, closing a stake of 20,836 shares — an estimated $523K sold.

Managed Account Advisors first reported a position in SGNT in Q4 2013 and held it in 5 quarters. The position peaked at $1.29M in Q1 2014. 127 funds tracked by Wall St. Rank hold SGNT as of Q1 2015.

Managed Account Advisors reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q1 2015 after selling out during the quarter.
Managed Account Advisors sold 20,836 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q1 2015, an estimated $523K.
Managed Account Advisors first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2013 and held it in 5 quarters.
Managed Account Advisors's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.29M in Q1 2014.
127 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q1 2015.

Based on Managed Account Advisors's 13F filing for Q1 2015, filed 15 May 2015.